SCHEMBL2962362

SCHEMBL2962362

Cc1ccccc1S(=O)(=O)ON1C(=O)CCC1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 3/20 0.62
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 6/20 0.49
KMT2A Q03164 6/20 0.49
MAPT P10636 5/20 0.49
F2 P00734 3/20 0.49
HTT P42858 2/20 0.49
XBP1 P17861 2/20 0.49
HPGD P15428 3/20 0.48
MEN1 O00255 3/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
VDR P11473 1/20 0.44
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
GAA P10253 1/20 0.42
CTSG P08311 1/20 0.42
CMA1 P23946 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31314906 0.81 KMT2A (0.50) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL2958322 0.81 ALDH1A1 (0.65) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL7784307 0.80 KDM4E (0.73) KDM4EALDH1A1KMT2AMAPTF2
SCHEMBL8702851 0.78 KMT2A (0.42) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL7973267 0.78 PARL (0.65) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL65216 0.78 PARL (0.58) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL7161148 0.78 PARL (0.58) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL64964 0.77 PARL (1.00) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL29369615 0.76 PARL (0.57) PARLKDM4EALDH1A1KMT2AMAPT
SCHEMBL452741 0.76 PARL (0.57) PARLKDM4EALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843935-B Dispersion liquid 住友化学株式会社 2021-07-27 CN disclosed
EP-2907156-A1 IMPRINTING METHOD AND CURABLE COMPOSITION FOR IMPRINTING Canon Kabushiki Kaisha (JP) 2015-08-19 EP disclosed
EP-2847233-A1 CURABLE COMPOSITION AND PATTERNING METHOD USING THE SAME Canon Kabushiki Kaisha (JP) 2015-03-18 EP disclosed
EP-2841255-A1 RESIN PRODUCTION METHOD AND RESIN PRODUCTION APPARATUS Canon Kabushiki Kaisha (JP) 2015-03-04 EP disclosed
EP-2791965-A1 PHOTOCURED PRODUCT AND METHOD FOR PRODUCING THE SAME Canon Kabushiki Kaisha (JP) 2014-10-22 EP disclosed
WO-2014084395-A1 IMPRINTING METHOD AND CURABLE COMPOSITION FOR IMPRINTING CANON KABUSHIKI KAISHA (JP) 2014-06-05 WO disclosed
WO-2014017505-A1 RESIN PRODUCTION METHOD AND RESIN PRODUCTION APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-01-30 WO disclosed
WO-2013183467-A1 CURABLE COMPOSITION AND PATTERNING METHOD USING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-12-12 WO disclosed
WO-2013118791-A1 PHOTOCURED PRODUCT AND METHOD FOR PRODUCING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-15 WO disclosed
US-7759045-B2 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-07-20 US disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
US-20090004601-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-01 US disclosed
US-6921623-B2 Active components and photosensitive resin composition containing the same KRI, INC. (JP) 2005-07-26 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed
US-20030064320-A1 Active components and photosensitive resin composition containing the same KRI, INC. (JP) 2003-04-03 US disclosed
EP-1265103-A1 ACTIVE COMPONENTS AND PHOTOSENSITIVE RESIN COMPOSITIONS CONTAINING THE SAME Kansai Research Institute, Inc. (JP) 2002-12-11 EP disclosed
US-6068962-A NOVOLAK RESIN AS AN ALKALI-SOLUBLE COMPONENT; QUINONEDIAZIDE; ACID GENERATOR; ANTHRACENE DERIVATIVE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-05-30 US disclosed
EP-0831371-A2 Positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM PARL 1844/4885KDM4E 1317/4885ALDH1A1 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.